Coca-Cola is about to report earnings. Here’s what to expect

Coca-Cola is about to report earnings. Here’s what to expect


Vintage Coca-Cola bottles are seen in a shop window in Manhattan, New York City, on July 15, 2024.

Beata Zawrzel | Nurphoto | Getty Images

Coca-Cola is about to report third-quarter earnings before the bell on Wednesday.

Here is what Wall Street analysts surveyed by LSEG are expecting:

  • Earnings per share: 74 cents
  • Revenue: $11.60 billion

In recent quarters, Coke has been besting rival PepsiCo, which has been hurt by the fallout from the Quaker foods recalls, a slowdown in snacking and lagging energy drink sales.

Coke has reported strong demand in its international markets, helping offset weaker demand in the U.S. In its home market, consumers have been dining out less, denting the company’s off-premise sales and prompting Coke to partner with chains to offer combo meals.

Despite domestic challenges, Coke hiked its full-year outlook last quarter, and executives expressed confidence in the company’s ability to meet those targets for the second half of the year. For 2024, Coke expects organic revenue growth of 9% to 10% and comparable earnings growth in a range between 5% and 6%.

Shares of Coke have risen 18% this year, raising the company’s market value to nearly $300 billion.

Don’t miss these insights from CNBC PRO



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More